UPCOMING WEBINAR: Roadmap to CNS Trial Success This webinar will cover how integrated, unified solutions can address the inherent complexities of CNS trial endpoint assessment, ensuring rater consistency and improving both patient and site experiences. Medidata Solutions Learn more & register: https://lnkd.in/gZTkpixT
The Conference Forum
研究服务
New York，NY 6,222 位关注者
Setting new standards in information exchange for the pharmaceutical and biotech industry.
关于我们
The Conference Forum has a very specific focus - developing specialized events for professionals in the life science industry. Our goal is to create the best content in an ideal forum for the exchange of ideas among peers and networking for pharmaceutical and biotech professionals. All of our conferences revolve around the mission of getting therapeutics to patients faster. ?
- 网站
-
theconferenceforum.org
The Conference Forum的外部链接
- 所属行业
- 研究服务
- 规模
- 11-50 人
- 总部
- New York，NY
- 类型
- 合营企业
- 创立
- 2011
- 领域
- Industry Research、Conference Development、Peer-to-Peer Networking、KOL Information & Lead Generation、Events、Webinars、Editorial、Newsletters、Clinical Research、Immuno-Oncology、Drug Delivery、Drug Development、Clinical Operations、Clinical Trials、Patient Engagement、Patient Centricity和Immuno Therapy
地点
-
主要
获取路线
1430 Broadway
Suite 1510
US，NY，New York，10018
The Conference Forum员工
-
Meredith Barbanell Sands
Co-Founder, Executive Director Business Development at The Conference Forum
-
Elizabeth Bard
Sales & Business Development Manager at The Conference Forum
-
Kate Woda
Life Science Research & Media Development
-
Shelby Casabura
Strategic Partnerships & Business Development Manager @ The Conference Forum | Communication
动态
-
Hear why Ulrich Bruggemann, Takeda, is looking forward to attending #PODD2024 and why he believes it's a valuable meeting space to connect with peers, start-ups and a variety of vendors. Learn more at poddconference.com #DrugDelivery #Networking #Partnering #DrugDevelopment #Conference
-
Join us at PODD! 14 years of being the gold standard in presenting a wide range of drug delivery technologies while presenting cutting-edge scientific and business trends in drug delivery. Learn more at poddconference.com Last Early Bird Ends This Friday September 27th! #PODD2024 #DrugDelivery #DrugDevelopment
-
-
#DPHARM2024 - another winner in the books!
?????????? ???????? ???????????? ???????? ?????????????? ???????? DPHARM is pleased to announce that Power is the winner of DPHARM Idol Disrupt at the 14th annual event. Power, represented by Brandon Li, Co-Founder, is building patient-friendly access to clinical trials, and is simplifying recruitment with a novel AI approach that delivers qualified referrals that match protocol criteria and supports the entire process through to enrollment. “Roughly 86% of all clinical trials are delayed due to an inability to recruit enough patients. By making it dead simple to discover and evaluate novel therapies, we’re hoping to offer patients a source of hope while reducing the time it takes for new breakthrough drugs to reach approval,” said Mr Li.? In front of 12 judges representing R&D executives, patient advocates, and life science investors, Power had six minutes to present how their platform helped patients navigate clinical trial options, scanned patient-uploaded medical documents for inclusion/exclusion criteria and matched patients to potential trials, and recommended nearby sites. Mr Li told the DPHARM audience that physicians and care providers had begun using the platform as well. “AI-driven curation of patient-friendly lay language is a game-changer. Power has unlocked access to clinical trials in a low-overhead, AI-forward way, and is helping patients not only find trials, but learn more about them and connect directly to a clinical research site,” said Nicole Sheetz, PharmD, Senior Director, Design & Innovation, Global Development, Gilead Sciences. “Patients are always looking for information, and it’s hard to make a decision in a pressurized environment. Power makes it clean, simple and user-friendly. When patients understand and retain information, especially from underrepresented communities, they are more likely to engage and exercise their options,” said Karen Peterson, Founder and Chief Patient Advocate, Karen's Club. Power had strong competition from the other DPHARM Idol Disrupt finalist contenders, which included: ? Beaconcure, represented by Ilan Carmeli, COO and CoFounder, and Sean Wall, SVP, Commercial ? ThoughtSphere, represented by Avi Kulkarni, PhD, CEO ? Inspire, represented by Brett Kleger, CEO ? ProofPilot , represented by Chris Venezia, CEO ? InSilicoTrials, represented by Mario Torchia, Chief Operating Officer, and MaryAnne Rizk, Ph.D., Advisor
-
-
Merck's, Adam Kinsey, shares why he's excited to be attending #CRAACO2024 for the first time and how clinical research as a care option can help improve access for patients. #ClinicalResearch #ClinicalTrials #Pharma #Hospitals #Healthcare
-
Hear why Candice Fitzgerald, Boehringer Ingelheim is excited to attend #CRAACO2024 next week and why she believes clinical research as a care option is essential for developing our medicines. #ClinicalResearch #ClinicalTrials #Pharma
-
The Conference Forum’s #CRAACO and #DPHARM are right around the corner, and we can’t wait – will you be in Philly September 16-18? Javara CEO Jennifer Byrne, Medical Director Colleen Purcell Tenan, MD, and Manager, Business Development Nicole S. will all be there and welcome the opportunity to meet with you. Shoot us a note or reach out directly!?????????????? ?? [email protected] ?? https://lnkd.in/gUfj2zv4 CRAACO: Clinical Research as a Care Option DPHARM: Disruptive Innovations to Modernize Clinical Research, John Worden, Beau Garland??????? ??????????????????????????????????????????????????????????????????????????????????????????????????? #javaralive #knowthepower #clinicalresearch #clinicaltrials #CRAACO2024 #DPHARM2024
-
-
Scientist | Rare Disease Patient | Clinical Trial Engagement Strategist | MM&M 40 under 40. Passionate about #humancentereddesign #treatingpatientsaspeople #marketingandcommunications #healthequity
The Conference Forum fall events are nearly here! While I’m taking some time off to embrace my latest chapter of motherhood, the Publicis Health team will be there in full force representing, so make sure you say hi! And don’t miss their session on how we’re using influencers to recruit hard to engage participants- it’s one not to miss! #CRAACO2024 #DPHARM2024 #patientrecruitment #patientengagement
I’ll be attending the CRAACO and DPHARM conferences in Philadelphia next week from Sept 16-18! ?? If you’re also going to be at these events or are in the Philadelphia area, I’d love to connect! Reach out to schedule time or use my scheduling link below. #CRAACO2024 #DPHARM2024 #PhillyConferences #ClinicalResearch #ClinicalTrials https://lnkd.in/eU73i-Vg
-
-
2024 Co-chair, Jeff James, Wilmington Health, shares what he's looking forward to at #CRAACO2024 and why clinical research as a care option is so important. #ClinicalResearch #ClinicalTrials #Hospitals #Pharma
-
I'm looking forward to attending the CRAACO conference this Monday. Hospital?systems together with pharma attend CRAACO to work through the convergence journey of getting more clinical trials into healthcare systems and community care centers.?Many thanks to Jennifer Byrne, Jeff James, Sean Lynch, Nadir AMMOUR, Kimberly Barnholt, Seema Asthana, Christina Brennan, MD, Susan Budinger, Joan Chambers, Madeline Sparks Cresswell, MBA, Candice Fitzgerald, Diana L. Foster, Ph.D., Faith L. Holmes, M.D., Adam Kinsey, Trevan Locke, PhD, Shalini V. Mohan, MD, Leticia Murray, MBA, Karen Peterson, Donna O'Brien, Tiffany Pearce, Alexander Saint-Amand, Rachel Sher, Denise Snyder, Meredith Zozus, PhD, CCDM among other wonderful contributors to form a first rate program agenda!! #CRAACO2024 #Clinicaltrials #ClinicalResearch #Hospitals #Pharmaceutical #Biotech #Patientsfirst craacoevent.com
-